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Abstract
Oilseed rape MS11 has been developed to confer male sterility and tolerance to glufosinate-ammonium-
containing herbicides. Based on the information provided in the application and in line with the scope of
application EFSA-GMO-BE-2016-138, the genetically modified organism (GMO) Panel concludes that the
molecular characterisation data and bioinformatic analyses do not identify issues requiring food/feed
safety assessment. None of the identified differences in the agronomic/phenotypic characteristics tested
between oilseed rape MS11 and its conventional counterpart needs further assessment. No conclusions
can be drawn for the compositional analysis due to the lack of an appropriate compositional data set. No
toxicological or allergenicity concerns are identified for the Barnase, Barstar and PAT/bar proteins
expressed in oilseed rape MS11. Owing to the incompleteness of the compositional analysis, the
toxicological, allergenicity and nutritional assessment of oilseed rape MS11 cannot be completed. In the
case of accidental release of viable oilseed rape MS11 seeds into the environment, oilseed rape MS11
would not raise environmental safety concerns. The post-market environmental monitoring plan and
reporting intervals are in line with the scope of the application. Since oilseed rape MS11 is designed to be
used only for the production of hybrid seed, it is not expected to be commercialised as a stand-alone
product for food/feed uses. Thus, seeds harvested from oilseed rape MS11 are not expected to enter the
food/feed chain, except accidentally. In this context, the GMO Panel notes that, oilseed rape MS11 would
not pose risk to humans and animals, while the scale of environmental exposure will be substantially
reduced compared to a stand-alone product.
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Summary
In the present scientific opinion, the scientific Panel on Genetically Modified Organisms of the
European Food Safety Authority (EFSA) (hereafter referred to as the ‘GMO Panel’) reports the outcome
of the risk assessment of oilseed rape MS11 in line with the scope of the application EFSA-GMO-BE-
2016-138 which is for import, processing and food and feed uses in accordance with Regulation (EC)
No 1829/2003. In delivering its scientific opinion, the GMO Panel took into account application EFSA-
GMO-BE-2016-138, additional information provided by the applicant, scientific comments submitted by
the Member States and relevant scientific publications. The GMO Panel conducted the assessment of
oilseed rape MS11 following the principles described in Regulation (EU) No 503/2013 and its applicable
guidelines for the risk assessment of genetically modified (GM) plants.
Oilseed rape MS11 is part of a breeding system intended to produce: (1) fertile oilseed rape hybrid
seed MS119RF3 (production scenario 1); and (2) new oilseed rape MS11 seed to maintain the line
(production scenario 2).
In line with the scope of the application EFSA-GMO-BE-2016-138, the GMO Panel concludes that:
• The molecular characterisation data establish that oilseed rape MS11 contains a single insert
consisting of one copy of the pat/bar, barnase and barstar expression cassettes. Bioinformatics
analyses of the sequences encoding the newly expressed proteins and other open reading
frames present within the insert or spanning the junctions between the insert and genomic
DNA do not indicate significant similarities to toxins and allergens. The stability of the inserted
DNA and of the introduced herbicide tolerance trait was confirmed over several generations.
The levels of the Barnase, Barstar and PAT/bar proteins were obtained and reported
adequately. The information provided on the protein characterisation indicate that the plant-
and E. coli-produced Barnase, Barstar and PAT/bar proteins are equivalent and the E. coli-
produced proteins can be used in the safety studies.
• The characteristics of the introduced traits of oilseed rape MS11 challenge the comparative
analysis to the extent that it is not possible to produce the materials and collect the data for
the comparative analysis without deviating from the requirements laid down in Regulation (EU)
No 503/2013. None of the differences between oilseed rape MS11 and its conventional
counterpart identified in the agronomic and phenotypic characteristics tested under the specific
theoretical cultivation scenarios needs further assessment. Because of the heterogeneous
genetic background of the seeds produced from oilseed rape MS11 treated with the intended
herbicide, the compositional data cannot be considered adequate for the comparative analysis.
Hence, no conclusions can be drawn for the compositional analysis.
• No toxicological and allergenicity concerns are identified regarding the Barnase, Barstar and
PAT/bar proteins as expressed in oilseed rape MS11. Owing to the incompleteness of the
compositional analysis, the toxicological, allergenicity and nutritional assessment of oilseed
rape MS11 cannot be completed.
• Oilseed rape MS11 would not raise safety concerns in the event of accidental release of viable
GM oilseed rape seeds into the environment.
• The post-market environmental monitoring (PMEM) plan proposed by the applicant is in line
with the scope of the application and agrees with its reporting intervals.
• Based on the relevant publications identified through the literature searches, no safety issues
pertaining to the uses of oilseed rape MS11 are identified. In the context of PMEM, the
applicant could further fine-tune future literature searches according to the GMO
Panel recommendations.
• In conclusion, in the absence of an appropriate comparative assessment and considering the
scope of application EFSA-GMO-BE-2016-138 as defined by the applicant (food and feed uses,
import and processing), the food/feed assessment of oilseed rape MS11 cannot be completed.
However, the GMO Panel concludes that the oilseed rape MS11 is unlikely to have any adverse
effect on the environment in the context of the scope of the application.
The GMO Panel notes that the oilseed rape MS11 is designed to be used only for the production of
hybrid seed in the frame of a dedicated breeding system and is thus not expected to be
commercialised as a stand-alone product for food/feed uses. Therefore, seeds harvested from oilseed
rape MS11 are not expected to enter the food/feed chain, except in the case of accidental presence in
products coming from non-EU countries. In this context, the GMO Panel notes that oilseed rape MS11
would not pose risks to humans and animals, while the scale of environmental exposure will be
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substantially reduced compared to a stand-alone product. On the other hand, the conclusions on the
molecular characterisation data and toxicity and allergenicity of the Barnase, Barstar and PAT/bar
proteins, as expressed in oilseed rape MS11 remain unchanged.
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1. Introduction
The scope of the application EFSA-GMO-BE-2016-138 is for food and feed uses, import and
processing of oilseed rape MS11 and does not include cultivation in the European Union (EU).
Oilseed rape MS11 was developed to confer male sterility and tolerance to the herbicidal active
substance glufosinate-ammonium.
Oilseed rape MS11 expresses the barnase gene encoding for a ribonuclease with cytotoxic activity.
Expression of the barnase gene is restricted to the tapetum cells during anther development by a
tissue-specific promoter leading to male sterility due to the lack of viable pollen. Oilseed rape MS11
also expresses the barstar gene under the weak Pnos constitutive promoter to produce the Barstar
protein. The Barstar protein forms a stable protein–protein complex with Barnase and inhibits its
activity. The prophylactic barstar gene is included to enhance transformation frequency by limiting the
negative effects of leaky expression of the barnase gene in undifferentiated plant tissues. In tapetum
cells of oilseed rape MS11 plants, the barstar expression is not sufficient to prevent the cytotoxic
effects of the barnase gene leading to the expected male sterile phenotype, while in the other tissues
the low-level expression of barstar plays no role.
Oilseed rape MS11 is part of a breeding system intended to produce: (1) fertile oilseed rape hybrid
seed MS119RF3 (production scenario 1, below); and (2) new oilseed rape MS11 seed to maintain the
line (production scenario 2, below).
As MS11 is male sterile, it must be pollinated by a male fertile plant to produce seeds. Thus,
considering the two production scenarios, the breeding system necessitates the use of three oilseed
rape lines:
• Oilseed rape MS11. This line is male sterile (MS) and serves as a ‘mother’ plant that can set
seed if pollinated by another oilseed rape plant during seed production.
• Oilseed rape RF3 (for scenario 1). This line is male fertile, serves as a pollen donor and
restores fertility (RF) in the progeny of oilseed rape MS11 when crossed with oilseed rape
MS11 during hybrid seed production. The RF3 line has a genetic background different from the
one of MS11.
• A maintainer line (for scenario 2). This line serves to maintain the oilseed rape MS11 line over
generations through the production of new oilseed rape MS11 seed. This line shares the same
genetic background as oilseed rape MS11 but lacks the MS trait.
Seeds derived from oilseed rape MS11 crossed with a fertile oilseed rape line (e.g. maintainer line)
will segregate 50:50 for the presence of event MS11. For this reason, a seed lot of oilseed rape MS11
is composed of a 50:50 mixture of seed containing/not containing the intended traits. Within the
intended breeding system, MS11 seed lots are used in the two different production scenarios as
follows:
• Scenario 1 (production of MS119RF3). The MS11 seed lot is sown adjacent to the RF line,
oilseed rape RF3. Upon treatment with glufosinate-ammonium containing herbicides, 50% of
the MS11 plants are killed; the remaining 50% will be male sterile and herbicide tolerant.
These MS11 plants will then be pollinated by the RF line. The resulting progeny (MS119RF3
hybrid seeds) will be marketed for sowing: the seeds are expected to show hybrid vigour and
superior yield (Wolko et al., 2019).
• Scenario 2 (production of new MS11). The MS11 seed lot is sown adjacent to a maintainer
line. Upon treatment with glufosinate-ammonium containing herbicides, 50% of the MS11
plants are killed; the remaining 50% will be male sterile and herbicide tolerant. These MS11
plants will be then pollinated by the maintainer line. The resulting progeny (MS11 seeds) will
be used to maintain the oilseed rape MS11 line for hybrid seed production (i.e. for scenario 1).
Based on the above-described breeding system, the GMO Panel notes that oilseed rape MS11 is
intended to be used only for the production of hybrid seed; it is not intended to be commercialised as
a stand-alone product for food and feed uses, import and processing. Hence, oilseed rape MS11 is not
expected to enter the food and feed chain in the EU, except in the case of accidental presence in
products coming from non-EU countries.
1.1. Background
On 16 December 2016, the European Food Safety Authority (EFSA) received from the Competent
Authority of Belgium application EFSA-GMO-BE-2016-138 for authorisation of Oilseed rape MS11
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(Unique Identifier BCS-BNØ12-7), submitted by Bayer CropScience (hereafter referred to as ‘the
applicant’) according to Regulation (EC) No 1829/20031.
Following receipt of application EFSA-GMO-BE-2016-138, EFSA informed EU Member States and the
European Commission, and made the application available to them. Simultaneously, EFSA published
the summary of the application.2
EFSA checked the application for compliance with the relevant requirements of EFSA guidance
documents, and, when needed, asked the applicant to supplement the initial application. On 08 March
2017, EFSA declared the application valid.
From validity date, EFSA and its scientific Panel on Genetically Modified Organisms (hereafter
referred to as ‘the GMO Panel’) endeavoured to respect a time limit of 6 months to issue a scientific
opinion on application EFSA-GMO-BE-2016-138. Such time limit was extended whenever EFSA and/or
its GMO Panel requested supplementary information to the applicant. According to Regulation (EC) No
1829/2003, any supplementary information provided by the applicant during the risk assessment was
made available to the EU Member States and European Commission (for further details, see the
section ‘Documentation’, below).
In accordance with Regulation (EC) No 1829/2003, EFSA consulted the nominated risk assessment
bodies of EU Member States, including national Competent Authorities within the meaning of Directive
2001/18/EC3. The EU Member States had 3 months to make their opinion known on application EFSA-
GMO-BE-2016-138 as of date of validity.
1.2. Terms of Reference as provided by the requestor
According to Articles 6 and 18 of Regulation (EC) No 1829/2003, EFSA and its GMO Panel were
requested to carry out a scientific risk assessment of oilseed rape MS11 in the context of its scope as
defined in application EFSA-GMO-BE-2016-138.
According to Regulation (EC) No 1829/2003, this scientific opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
The relevant information is made available in the EFSA Register of Questions including the
information required under Annex II to the Cartagena Protocol; a labelling proposal; a Post-Market
Environmental Monitoring (PMEM) plan as provided by the applicant; the method(s), validated by the
Community reference laboratory, for detection, including sampling, identification of the transformation
event in the food–feed and/or foods–feeds produced from it and the appropriate reference
materials.2
2. Data and methodologies
2.1. Data
The GMO Panel based its scientific risk assessment of oilseed rape MS11 on the valid application
EFSA-GMO-BE-2016-138, additional information provided by the applicant during the risk assessment,
scientific comments submitted by EU Member States and relevant peer-reviewed scientific publications.
In addition to this comprehensive information package, the GMO Panel also received unpublished
studies submitted by the applicant in order to comply with the specific provisions of Regulation (EU)
No 503/2013. A list of these additional unpublished studies is provided in Appendix A.
2.2. Methodologies
The GMO Panel conducted its assessment in line with the principles described in Regulation (EU) No
503/2013, its applicable guidelines (i.e. EFSA GMO Panel, 2010a,b, 2011a,b, 2015) and explanatory
notes (i.e. EFSA, 2014, 2017a,b) for the risk assessment of GM plants. During its risk assessment, the
GMO Panel also considered all additional unpublished studies as listed in Appendix A for potential
effects on human and animal health and the environment.
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified
food and feed. OJ L 268, 18.10.2003, p. 1–23.
2 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2016-00857
3 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38.
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For the 90-day animal feeding study, the GMO Panel took into account the criteria included in the
2011 EFSA Scientific Committee guidance on conducting repeated-dose 90-day oral toxicity study in
rodents on whole food/feed (EFSA Scientific Committee, 2011) and the explanatory statement for its
applicability (EFSA, 2014).
The GMO Panel also assessed the applicant’s literature searches, which include a scoping review, in
accordance with the recommendations on literature searching outlined in EFSA (2010, 2017a). In the
frame of the contracts OC/EFSA/GMO/2013/01 and OC/EFSA/GMO/2014/01, contractors performed
preparatory work and delivered reports on the methods applied by the applicant in performing
bioinformatic and statistical analyses, respectively.
3. Assessment
3.1. Systematic literature review4
The GMO Panel assessed the applicant’s literature searches on oilseed rape MS11, which include a
scoping review, according to the guidelines given in EFSA (2010).
A systematic review as referred to in Regulation (EU) No 503/2013 was not provided in support to
the risk assessment of application EFSA-GMO-BE-2016-138. Based on the outcome of the scoping
review, the GMO Panel agrees that there is limited value of undertaking a systematic review for oilseed
rape MS11 at present.
Although the overall quality of the performed literature searches is acceptable, the GMO
Panel considers that future searches on oilseed rape MS11 could be further improved. The GMO
Panel therefore recommends the applicant to use proximity operators that allow searching for terms
that are adjacent in any order.
None of the relevant publications identified through the literature searches reported information
pointing to safety issues associated with the intended uses of oilseed rape MS11.
3.2. Molecular characterisation
3.2.1. Transformation process and vector construct5
Oilseed rape MS11 was developed by Agrobacterium tumefaciens (also known as Rhizobium
radiobacter) mediated transformation of embryogenic callus derived from hypocotyl segments of
oilseed rape (Brassica napus) variety N90-740 seeds with plasmid vector pTCO113. A helper Ti-plasmid
pGV4000 was also used in the transformation process.
The plasmid pTCO113 used for the transformation contained three expression cassettes between
the right and left borders of the T-DNA: pat/bar, barnase and barstar.
The pat/bar expression cassette contains the following genetic elements: the promoter region of the
ribulose-1,5-biphosphate carboxylase small subunit gene from Arabidopsis thaliana (PssuAt), the coding
sequence of the phosphinothricin acetyl transferase gene from Streptomyces hygroscopicus (bar) and
the 30 untranslated region of the TL-DNA gene 7 from the A. tumefaciens octopine Ti plasmid (30g7).
The barnase expression cassette contains the following genetic elements: the promoter of the
anther-specific gene TA29 from Nicotiana tabacum (Pta29), the coding sequence and 30 untranslated
region of the barnase gene from Bacillus amyloliquefaciens and 30 untranslated region of the nopaline
synthase gene (30nos) from the T-DNA of pTiT37. The barstar expression cassette contains the
following genetic elements: the promoter region of the nopaline synthase (Pnos) gene from
A. tumefaciens, the coding sequence of the barstar gene from Bacillus amyloliquefaciens, and the
30 untranslated region of the TL-DNA gene 7 from the A. tumefaciens octopine Ti plasmid (30g7).
The vector backbone contained elements necessary for the maintenance of the plasmid in bacteria
and a fragment containing the barstar gene.
3.2.2. Transgene constructs in the GM plant6
Molecular characterisation of oilseed rape MS11 was performed by Southern analysis, polymerase
chain reaction (PCR) and DNA sequence analysis, in order to determine insert copy number, size and
4 Dossier: Part II – Section 7; Additional information: 24/8/2018 and 14/6/2019.
5 Dossier: Part II – Section 1.2.1.
6 Dossier: Part II – Section 1.2.2.2; additional information 21/1/2020.
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organisation of the inserted sequences and to confirm the absence of plasmid backbone sequences.
The approach used was acceptable in terms of coverage and sensitivity.
Southern analyses indicated that oilseed rape MS11 contains a single insert, which consists of a
single copy of the T-DNA in the same configuration as in the pTCO113. The insert and copy number
were confirmed by multiple restriction enzyme/probe combinations covering the T-DNA region and
flanking regions. PCR analyses confirmed the results obtained by the Southern analyses. The absence
of vector backbone sequences was demonstrated by Southern analysis using backbone-specific
overlapping probes.
The nucleotide sequence of the entire insert of oilseed rape MS11 together with 1,129 bp of the 50
and 1,302 bp of the 30 flanking regions was determined. The insert of 5,778 bp is identical to the T-
DNA of pTCO113, except for the truncation of the border regions. A comparison of the flanking regions
with the pre-insertion locus indicated that 40 bp of the parental genomic sequence had been deleted
upon transformation. The possible interruption of known endogenous oilseed rape genes by the
insertion in event MS11 was evaluated by bioinformatic analyses of the pre-insertion locus and of the
genomic sequences flanking the insert. The results of these analyses did not reveal the interruption of
any known endogenous gene in the oilseed rape MS11.
The results of segregation (see Section 3.2.5) and bioinformatic analyses established that the insert
is located in the nuclear genome.
Updated bioinformatic analyses of the amino acid sequences of the newly expressed Barnase,
Barstar and PAT/bar proteins revealed no significant similarities to known toxins and allergens. In
addition, updated bioinformatic analyses of the newly created open reading frames (ORFs) within the
insert or spanning the junctions between the insert and genomic DNA did not indicate significant
similarities to toxins and allergens.
In order to assess the possibility for horizontal gene transfer by homologous recombination (HR),
the applicant performed a sequence identity analysis of the regions of bacterial origin in oilseed rape
MS11. The likelihood and potential consequences of plant to bacteria gene transfer are described in
Section 3.5.1.2.
3.2.3. Protein characterisation and equivalence7
Oilseed rape MS11 expresses three new proteins Barnase, Barstar and PAT/bar.
Given the technical restraints in producing large enough quantities for safety testing from plants,
these proteins were recombinantly produced in Escherichia coli. Prior to safety studies, a set of
biochemical methods was employed to demonstrate the equivalence between oilseed rape and E.coli-
produced proteins. Purified proteins from these two sources were characterised and compared in
terms of their physico-chemical, structural and functional properties.
3.2.3.1. Barnase characterisation and equivalence
Considering the insert design, Barnase expression in oilseed rape MS11 is expected to be low and
limited to only flower buds during anther development. Furthermore, based on the data submitted by
the applicant, Barnase could not be detected by western blot analysis in crude extracts or immuno-
affinity purified samples. Consequently, Barnase could not be extracted at sufficient quantity to
experimentally demonstrate its equivalence with the E.coli-produced Barnase protein. Based on this
information, a weight of evidence approach was employed by the applicant to demonstrate the
equivalence between the plant and the E. coli-produced Barnase proteins. Amino acid sequence
analysis of the E. coli-produced protein by mass spectrometry methods showed that it was 100%
identical to the Barnase amino acid sequence deduced from the nucleotide sequence of the insert in
oilseed rape MS11. Furthermore, the activity of the plant-derived Barnase protein was demonstrated
in vivo by the male sterile phenotype exhibited by oilseed rape MS11 plants and the activity of the
E.coli-produced protein was shown by a biochemical in vitro activity assay.
3.2.3.2. Barstar characterisation and equivalence
The expression of Barstar in oilseed rape MS11 is low; however, a concentrated crude protein
extract from roots was used to carry out a western blot analysis. This analysis showed that plant and
E.coli-produced Barstar proteins had the expected molecular weight of ~ 10 kDa and were comparably
immunoreactive to Barstar protein-specific antibodies. Due to the low expression in oilseed rape MS11,
7 Dossier: Part II – Section 1.4.1.
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Barstar could not be extracted in sufficient quantity to further experimentally demonstrate its
equivalence with the E. coli-produced Barstar protein. Amino acid sequence analysis of the E.coli-
produced Barstar by mass spectrometry methods showed that it was 100% identical to the Barstar
amino acid sequence deduced from the nucleotide sequence of the insert in oilseed rape MS11. The
function of Barstar in forming a protein–protein complex with Barnase is demonstrated in vivo by its
prophylactic role in preventing the cytotoxic activity of Barnase in cells other than tapetum and in vitro
by a study on the temperature-dependent Barnase–Barstar complex formation using the E.coli-
produced protein.
3.2.3.3. PAT/bar characterisation and equivalence
SDS-PAGE and western blot analysis showed that plant and microbe-derived PAT/bar proteins had
the expected molecular weight of ~ 20.5 kDa and were comparably immunoreactive to PAT/bar
protein-specific antibodies. In addition, glycosylation detection analysis demonstrated that none of the
PAT/bar proteins were glycosylated. Amino acid sequence analysis by mass spectrometry and N-
terminal sequencing methods showed that both proteins showed that the protein matched the
deduced sequence as defined by the pat/bar gene. These data also showed that the N-terminal
methionine of the plant-derived PAT/bar protein was acetylated. Such modifications are common in
eukaryotic proteins (e.g. Polevoda and Sherman, 2000) and have been previously assessed by the
GMO Panel for proteins newly expressed in GM plants (e.g. EFSA GMO Panel, 2017a). Functional
equivalence was demonstrated by a biochemical in vitro activity assay which showed that both proteins
had comparable activity for the intended herbicide.
The protein characterisation data comparing the structural, biochemical and functional properties of
plant and microbial PAT/bar proteins indicate that these proteins are equivalent. Barnase and Barstar
expression in MS11 plants is low, and therefore, they could not be extracted at sufficient amounts to
experimentally demonstrate their equivalence with the E.coli-produced proteins. Thus, a weight of
evidence approach was employed to demonstrate the equivalence between the plant and the E. coli-
produced Barnase and Barstar proteins. The GMO Panel considered the provided information sufficient
and therefore accepts the use of the Barnase, Barstar and PAT/bar proteins produced in E.coli for the
safety studies.
3.2.4. Information on the expression of the insert8
Protein levels of Barnase, Barstar and PAT/bar were analysed by enzyme-linked immunosorbent
assays (ELISA) in material harvested in a field trial across three locations in the USA and Canada
during the 2014 growing season. Samples analysed included whole plant (3–5 leaves, stem elongation
and first flowering), root (stem elongation and first flowering), raceme (first flowering) and seed
(maturity) both those treated and non-treated with glufosinate.
Although barnase expression is driven by a tissue-specific promoter, the applicant designed a
system to prophylactically express barstar under a constitutive promoter in order to counteract the
expression of barnase outside the anther. Thus, the GMO Panel assumed that the unintended barnase
expression cannot be excluded and could potentially lead to the formation of a Barnase–Barstar
complex elsewhere in the MS11 plant. Additional ELISA-derived data submitted by the applicant using
purified Barnase and Barstar proteins indicated that when Barnase and Barstar are complexed and
under the conditions of the performed ELISA, (i) 35.5% of the complexed Barnase protein amount can
be measured and (ii) the Barstar protein is undetectable. Based on the above elements, the applicant
provided estimated values of the highest possible levels of Barnase and Barstar in the different plant
tissues taking into account both the complexed and the uncomplexed fractions of these proteins.9,10
The mean values, standard deviations and ranges of protein expression levels in seeds of the PAT/bar,
Barnase and Barstar proteins as determined by ELISA are summarised in Table 1. Based on the
calculations performed by the applicant to estimate the highest possible levels for Barnase and Barstar in
8 Dossier: Part II – Section 1.2.2.3; 11/08/2017, 13/03/2018, 01/06/2018, 24/08/2018, 01/04/2019, 21/11/2019.
9 All ELISA measurements for Barnase were below the LLOQ (0.05 µg/g fresh weight) so in order to calculate the Barnase
amount that could be complexed with Barstar, the LLOQ was considered as the maximum Barnase concentration and a
correction factor of 35.5% (% Barnase that could be detected when in complex with Barstar) was applied to this value based
on the ELISA performance.
10 The bound Barstar in the complex was calculated using the estimated bound Barnase, the molecular weights of Barnase and
Barstar and the one-to-one molar ratio of Barnase/Barstar in the complex. To calculate the total Barstar levels, the unbound
Barstar fraction was added to the complexed Barstar fraction. What was considered as the uncomplexed Barstar fraction was
either any quantifiable Barstar measurement or the LLOQ (0.025 µg/g fresh weight) when the measurement was < LLOQ.
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seeds, the total levels for these proteins were: Barnase: = 0.14 lg/g fresh weight (0.159 lg/g dry weight
based on the reported average 12% moisture)11 and Barstar = 0.145 lg/g fresh weight (0.165 lg/g dry
weight based on the reported average 12% moisture).12 These estimated values together with the
values of PAT/bar levels as determined by ELISA were used to estimate human and animal dietary
exposure (see Section 3.4.5).
3.2.5. Inheritance and stability of inserted DNA
Genetic stability of the oilseed rape MS11 insert was assessed by Southern analysis of genomic
DNA from five generations and PCR-based and herbicide tolerance trait-based segregation analysis. For
the Southern analysis, the restriction enzyme/probe combinations used were sufficient to conclude that
all the plants tested retain the single copy of the insert and flanking regions, which were stably
inherited in subsequent generations.
The results supported the presence of a single insertion, segregating in a Mendelian fashion.
3.2.6. Conclusions on molecular characterisation
The molecular characterisation data establish that oilseed rape MS11 contains a single insert
consisting of one copy of the barnase, barstar and pat/bar expression cassettes. Bioinformatic analyses
of the sequences encoding the newly expressed proteins and other ORFs present within the insert or
spanning the junctions between the insert and genomic DNA did not indicate significant similarities to
toxins and allergens. The stability of the inserted DNA and of the introduced herbicide tolerance trait
was confirmed over several generations. The levels of the Barnase, Barstar and PAT/bar proteins were
obtained and reported adequately.
The information provided on the protein characterisation indicate that the plant- and E.coli-
produced Barnase, Barstar and PAT/bar proteins are equivalent and the E.coli-produced proteins can
be used in the safety studies.
3.3. Comparative analysis
As described in Section 1, oilseed rape MS11 in intended to be used only to produce hybrid seed in
the frame of the dedicated breeding system and thus not be commercialised as a stand-alone product
for food and feed uses, import and processing. A challenging aspect for the risk assessment of oilseed
rape MS11 is that this is a plant that is not designed to be cultivated for food and feed production as
such but always stacked with a RF line. The breeding system with oilseed rape MS11 is intended to
produce: (1) fertile hybrid oilseed rape (i.e. MS11 9 RF3) seed (scenario 1, see Section 1); and (2)
new oilseed rape MS11 seed to maintain the oilseed rape MS11 line (scenario 2, see Section 1).
Neither of these two production scenarios is in line with the requirements laid down in Regulation (EU)
No 503/2013, which was specifically developed to reflect cultivation conditions for food and feed uses,
as opposed to breeding purposes. The GMO Panel notes how the characteristics of the introduced
traits of oilseed rape MS11 challenge the comparative analysis to the extent that it is not possible to
produce the materials and collect the data for the comparative analysis without deviating from the
requirements laid down in Regulation (EU) No 503/2013. For this reason, deviations from scenario 1
for the commercial production of MS11 9 RF3 hybrid seeds and scenario 2 for the maintenance of
MS11 seeds were made by the applicant in order to conduct the comparative analysis.
Table 1: Mean values, standard deviations and ranges of PAT/bar, Barnase and Barstar in seeds
[lg/g fresh weight (fw) and lg/g dry weight (dw)] of oilseed rape MS11
Glufosinate-ammonium treatment
Not treated Treated
Seeds (maturity)
PAT/bar(a) 0.30  0.17/0.34  0.18
(Ranges FW: (0.06–0.56); DW: (0.06–0.59)
0.44  0.18/0.49  0.18
(Ranges FW: (0.27–0.77); DW: (0.31– 0.84)
Barnase < LLOQ(b) < LLOQ
Barstar < LLOQ < LLOQ
(a): n = 9 and n = 15 for untreated and treated samples, respectively.
(b): LLOQ: Lower Limit of Quantification.
LLOQ for Barnase: 0.05 lg/g fw; LLOQ for Barstar: 0.025 lg/g fw.
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For the purpose of assessing the comparative analysis, the GMO Panel considered two additional
hypothetical scenarios (3 and 4 below) for the cultivation of MS11 for food and feed uses. The
scenarios are based on application EFSA-GMO-BE-2016-138 and tailored on the specific management
conditions used in the field trials for the cultivation of MS11 in the absence (scenario 3) or presence
(scenario 4) of glufosinate-ammonium containing herbicides. In the two scenarios, oilseed rape MS11
is not crossed with oilseed rape RF3 or with the maintainer line: as a result, hybrid MS11 9 RF3 seeds
and MS11 seeds to maintain the line (the products of the original breeding system) are not produced,
the only product being MS11 for food and feed uses. For this reason, and because they do not bring
any agronomic advantage to the farmer, the two scenarios must be considered unrealistic.
• Scenario 3: a seed lot of oilseed rape MS11 (50:50 mixture of seeds containing/not containing
the intended traits) is sown for cultivation. Glufosinate-ammonium is not applied. The MS11
plants will be pollinated by the male fertile plants not containing MS11 that are present within
the seed lot at sowing. The harvest will be constituted by genetically homogeneous seeds
except for event MS11 which will be present in 25% of the seeds. This is considered a
theoretical scenario because, from an agronomic point of view, there is no advantage in
sowing seeds containing an MS trait, where the seed set is always dependent on the
availability of pollen from fertile plants.
• Scenario 4: a seed lot of oilseed rape MS11 (50:50 mixture of seeds containing/not containing
the intended traits) is sown for cultivation. Glufosinate-ammonium is applied and 50% of the
MS plants (those without the intended trait) is selectively destroyed. The remaining sterile,
glufosinate-ammonium-tolerant MS11 plants will produce seeds only if pollinated by fertile
oilseed rape plants that are present in the neighbouring fields. Because of the dynamics of
pollen transfer for oilseed rape and of the requirement for synchronous flowering to occur, the
extent of seed formation could be significantly reduced compared to scenarios 1, 2 and 3. In
addition, the seeds produced will have a genetic background influenced by the genotype of the
pollen that fertilised the MS11 plant and only 50% of them will be harbouring event MS11.
This is considered a theoretical scenario because it would expose the farmer to a low/no yield
scenario and is therefore agronomically unrealistic.
3.3.1. Overview of studies conducted for comparative analysis
Application EFSA-GMO-BE-2016-138 presents data on agronomic/phenotypic characteristics as well as
on forage and seed composition of oilseed rape MS11 (see Table 2). The field trial studies, conducted in
support of application EFSA-GMO-BE-2016-138, correspond to the cultivation scenarios 3 and 4 described
above. In addition, the application contains data on seed characteristics of oilseed rape MS11.
3.3.2. Experimental field trial design and statistical analysis
At each field trial site, the following materials were grown: oilseed rape MS11, the comparator N90-
740 and three commercial non-GM oilseed rape reference varieties, all treated with conventional
Table 2: Main comparative analysis studies to characterise the GM oilseed rape MS11 provided in
application EFSA-GMO-BE-2016-138
Study focus Study details Comparator
Non-GM reference
varieties
Agronomic and
phenotypic analysis
Field study, 6 sites(a) in Canada and
3 sites(b) in USA in 2014 and additional 4 sites(c)
in Canada in 2016
N90-740 6(d)
Compositional analysis Field study, 6 sites(a) in Canada and
3 sites(b) in USA in 2014
(a): The 2014 Canadian field trials were located in Wakaw, Saskatchewan; Gibbons, Alberta; MacGregor, Manitoba; Starbuck,
Manitoba; Minto, Manitoba and Saskatoon, Saskatchewan.
(b): The 2014 US field trials were located in Northwood, North Dakota; Jerome, Idaho and Ephrata, Washington. A field trial
established in Gardner, North Dakota and was removed from the study due to unfavourable weather conditions resulting on
poor emergence.
(c): The 2016 Canadian field trials were located in St-Marc-sur-Richelieu Quebec; Bon Accord, Alberta; Hepburn Saskatchewan
and Elm Creek Manitoba.
(d): The oilseed rape non-GM reference lines used in the field trials are: 46A65, AC Elect, AC Excel, Peace, Spectrum and Westar.
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herbicides management regimes; and oilseed rape MS11 exposed to the intended glufosinate-
ammonium-containing herbicide, in addition to the conventional herbicides.
The GMO Panel makes the following remarks on the adequacy of the data for oilseed rape MS11:
• Data from F1 plants, i.e. all agronomic-phenotypic endpoints except those harvest-related. The
data for oilseed rape MS11 are considered adequate, as 50% of the oilseed rape MS11 plants
contain the intended traits (however, early stand count is an exception because of double seed
density, see Section 3.3.4.3).
• Data from F2 seeds, i.e. all compositional endpoints and the harvest-related agronomic
endpoints. Two cases must be considered, depending on herbicide treatment:
– For plots with MS11 not treated with the intended herbicide (see hypothetical scenario 3),
event MS11 will be present in 25% of the harvested seeds. From the context of a
comparative assessment, it is considered that these data are adequate under the specific
conditions of this application and thus, all the endpoints collected during the life cycle of
the MS11 plants are adequate.
– For plots with MS11 treated with the intended herbicide (see hypothetical scenario 4),
event MS11 will be present in 50% of the harvested seeds. However, the genetic
background of the seeds will be heterogeneous and location-dependent, as it will be
influenced by the genotype of the pollen produced from nearby plots (oilseed rape N90-
740 and the reference varieties present at the specific site). For this reason, harvest-
related agronomic data and compositional data for MS11 treated with the intended
herbicide are not considered adequate for the comparative analysis.
The agronomic, phenotypic and compositional data were analysed by the applicant as specified by
the EFSA GMO Panel (2010b, 2011b). This includes, for each of the two treatments of oilseed rape
MS11, the application of a difference test (between the GM oilseed rape and its comparator) and an
equivalence test (between the GM oilseed rape and the set of non-GM-oilseed rape reference
varieties).11 The results of the equivalence test are categorised into four possible outcomes (I-IV,
ranging from equivalence to non-equivalence).12
3.3.3. Suitability of selected test materials
3.3.3.1. Selection of the GM oilseed rape line and comparator
To obtain the GM oilseed rape MS11, the conventional oilseed rape N90-740 was used as recipient
line for the transformation. Due to the nature of the MS trait, the obtained T0 MS11 hemizygous line was
backcrossed with the fertile non-GM oilseed rape line N90-740 (maintainer) to produce the T1
generation. This process was repeated to produce the T4 generation that was used for the comparative
studies reported in Table 2. Oilseed rape N90-740 was not only used as the maintainer line but was also
selected as the comparator being genetically as close as possible to the produced MS11 line. While
oilseed rape N90-740 is fertile and this makes its life cycle different compared with MS11, the GMO
Panel has evaluated the biological differences between oilseed rape N90-740 and MS11 and in light of
the close genetic similarity considers oilseed rape N90-740 as an acceptable comparator.
The GM MS11 oilseed rape cannot be considered a representative line for commercial cultivation
since, as a single event, it will not be cultivated by farmers (see Section 1). However, to conduct the
comparative assessment, the selection of the MS11 line in the N90-740 genetic background is
considered appropriate for the scope of these analyses. However, the GMO Panel notes that the MS11
seeds produced under scenario 4 are characterised by a heterogeneous genetic background (instead
of N90-740), as influenced by the genotype of the pollen produced from nearby plots, and thus, they
are not suitable for the comparative analysis (see Section 3.3.2).
11 The purpose of the test of equivalence is to evaluate the estimated mean values for oilseed rape MS11 taking into account
natural variability as defined by a set of commercial non-GM oilseed rape reference varieties with a history of safe use for
consumption as food or feed.
12 In detail, the four outcomes are: category I (indicating full equivalence to the non-GM reference varieties); category II
(equivalence is more likely than non-equivalence); category III (non-equivalence is more likely than equivalence); and
category IV (indicating non-equivalence).
Assessment of oilseed rape MS11
www.efsa.europa.eu/efsajournal 14 EFSA Journal 2020;18(5):6112
3.3.3.2. Selection of commercial non-GM oilseed rape reference varieties
To conduct the comparative field trials, six non-GM reference varieties (see Table 2) were selected.
Three reference varieties were grown at each site of the field trials conducted in 2014 and 2016. The
selected non-GM reference varieties are commercial oilseed rape lines present in national and
international lists of varieties. The GMO Panel notes that non-GM sterile lines are not commercially
available. It is therefore considered that the selected reference varieties were acceptable to support
the comparative analysis, in line with the Regulation (EC) No 503/2013.
3.3.3.3. Seed production and quality
The seeds of GM oilseed rape MS11 and the conventional counterpart used in the field trials (see
Table 2) were produced, harvested and stored under similar conditions. As described in the
Introduction, under this breeding system, MS11 seed production leads to seed lots constituted by an
equal mix of MS11 and non-GM-segregant seeds. The seed lots were verified for their purity via event-
specific quantitative polymerase chain reaction analysis. The seeds were tested for their germination
capacity at two different temperatures.13 The data obtained from seed germination studies were
analysed with Fisher’s Exact test. The results of these studies indicate that the seed germination of GM
oilseed rape MS11 is not different than that of the conventional counterpart (N90–740). The GMO
Panel considers that the starting seed used as test material in the agronomic, phenotypic and
compositional studies was of suitable quality.
3.3.3.4. Conclusion on suitability
The GMO Panel is of the opinion that oilseed rape MS11, its conventional counterpart and the
selected non-GM oilseed rape reference varieties are of adequate quality. The GMO Panel considers
part of the selected materials acceptable considering the presence of the MS trait in the MS11 line for
which the cultivation for food and feed uses only represents a theoretical scenario (see Introduction
and above). However, MS11 seeds produced under scenario 4 are not considered appropriate for the
comparative analysis.
3.3.4. Appropriateness of the receiving environments
MS11 is a line that does not represent an agronomically valuable material for food and feed
cultivation and it is not expected to be grown by farmers. Therefore, the cultivation of MS11 line for
food and feed production represents per se a lack of representativeness. In this specific context, the
GMO Panel assessed the appropriateness of the selected field trials considering the theoretical
cultivation scenarios 3 and 4 described in Section 3.3.
3.3.4.1. Selection of field trial sites
The selected field trial sites were located in commercial oilseed rape-growing regions of North
America and Canada. Soil and climatic characteristics of the field trial sites are diverse,14 corresponding
to optimal, near-optimal and suboptimal conditions for oilseed rape cultivation (Sys et al., 1993). The
GMO Panel considers that the selected sites reflect commercial oilseed rape-growing regions.
3.3.4.2. Meteorological conditions
Maximum and minimum mean temperatures and sum of precipitations were provided on a monthly
basis for sites conducted in 2014 and on a weekly basis for sites conducted in 2016. Some exceptional
weather conditions were reported at two of the selected sites.15 However, due to the lack of major
impacts on plant growth at these sites, the GMO Panel considers that the exceptional weather
conditions did not invalidate the selection of the field trial sites for the comparative analyses.
13 Test conducted following the AOSA guideline for seeds testing under warm and cold temperature. Warm temperature regime:
cyclical temperature of 16 and 8 h at 20  5°C/30  5°C for 7 days in the dark. Cold temperature regime: constant temperature
at 10  5 °C for 7 days followed by cyclical temperature of 16 and 8 h at 20  5°C/30  5°C for 7 days in the dark.
14 Soil types of the field trials were sandy loam, loam, clay, silt loam, sandy clay loam and loamy sand; soil organic matter
ranged from 1.7% to 8.5%; pH ranged from 5.3 to 8.4; historical mean temperatures and sum of precipitations during the
growing season ranged, respectively, from 12.4°C to 19.2°C and from 57 to 354 mm.
15 Excessive rains occurred at St-Marc-sur-Richelieu Quebec from 12/8/2016 to 21/8/2016 and Elm Creek Manitoba in 2016 from
25/5/2016 to 31/5/2016.
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3.3.4.3. Management practices
The field trials included plots containing oilseed rape MS11,16 plots with the conventional
counterpart and plots with non-GM oilseed rape reference varieties. Considering the occurrence of the
MS and the glufosinate-tolerant traits, the field trials were managed largely according to local
agricultural practices, but some specific deviations were introduced. In addition, the field trials included
plots containing oilseed rape MS11 managed following the same practices and exposed to the intended
glufosinate-ammonium-containing herbicide. The plots containing the oilseed rape MS11 plants were
sown using the MS11 seed lot that are constituted by a mix of 50% hemizygous plants (male sterile
and glufosinate-ammonium-tolerant) and 50% of negative plants for MS11 (fertile and glufosinate-
ammonium-susceptible). The plots containing GM plants exposed to the intended herbicide were
planted at double seed density compared to the plots exposed to conventional herbicides. This
management practice was applied to compensate the loss of the 50% negative MS11 plants that were
present in the MS11 plots. This agronomic practice represents a deviation from standard management
practices under farm cultivation. For this reason, the GMO Panel considered that the endpoint early
stand count for MS11 exposed to the intended herbicide is not adequate for the comparative analysis.
The glufosinate-ammonium containing herbicide was applied at the growth-stage BBCH12-14.
3.3.4.4. Conclusion on the representativeness
The GMO Panel concludes that under the specific theoretical cultivation scenarios considered, the
geographical locations, soil characteristics, meteorological conditions and management practices of the
field trials including planting, harvesting and application of plant protection products are appropriate
for conducting the comparative assessment of oilseed rape MS11.
3.3.5. Conclusion on the appropriateness of the data for the comparative
analysis
Under the specific theoretical cultivation scenarios considered, the GMO Panel is of the opinion that
the generated data are only partially in line with the requirements of Regulation (EC) No 503/2013. As
described in Section 3.3.2, the seeds produced from MS11 treated with intended herbicide (scenario 4)
have a heterogeneous genetic background influenced by the genotype of the pollen produced from
nearby plots. Hence, the GMO Panel considered that the compositional data and the harvest-related
agronomic data generated for MS11 treated with the intended herbicide are not adequate.
3.3.6. Agronomic and phenotypic endpoints
Thirteen17 agronomic and phenotypic endpoints, including data on biotic and abiotic stressors and
herbicide injury, were collected from all field trials (see Table 2).18
Six of the endpoints19 were measured as categorical data and not considered suitable for a
parametric analysis. For those endpoints, differences between the GM oilseed rape and its conventional
counterpart were investigated with a generalised Cochran–Mantel–Haenszel (CMH) test. Statistically
significant differences were identified between oilseed rape MS11 and its conventional counterpart for
seedling vigour and abiotic stress rating (stage BBCH 30-39).20 For these endpoints, the average
values fell within the range of the commercial reference varieties.
16 The plots containing the oilseed rape MS11 plants, were constituted using seeds derived from a MS11 (sterile) plant crossed
with line N90-740 (maintainer), these seeds are constituted by a mix of 50% hemizygous plants (male sterile and glufosinate
tolerant) and 50% of negative plants for MS11 (fertile and sensitive to glufosinate).
17 Early stand count, final stand count, days to flowering (50% plants flower), days to flowering – 10% remains, days to
maturity, average plant height, seed yield, seedling vigour, lodging resistance, pod shattering, disease stress rating (assessed
at four different times during the growing season), insect stress rating (at four different times) and abiotic stress rating (at
four different times).
18 Three additional endpoints (fruit count, thousand seed weight and herbicide injury stressor) were measured only in four field
trial sites and not evaluated further. Data for sterile plant count were also collected from 8 study sites, but only used to
confirm the efficacy of the male sterile trait.
19 Categorical endpoints: seedling vigour, lodging resistance, pod shattering, disease stress rating (assessed at four different times
during the growing season), insect stress rating (at four different times) and abiotic stress rating (at four different times).
20 Average rating for seedling vigour: 7.5 (oilseed rape MS11 treated with the target herbicide) and 6.6 (conventional
counterpart). Average abiotic stress rating (stage BBCH 30-39): 2.1 (oilseed rape MS11 treated with the target herbicide) and
1.6 (conventional counterpart).
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The test of difference and the test of equivalence were applied to the remaining seven endpoints,21
with the following results:
• For oilseed rape MS11 treated with conventional herbicides, the test of difference identified no
statistically significant differences with the conventional counterpart.
• For oilseed rape MS11 treated with the intended herbicides, the GMO Panel considered only
the results for the adequate endpoints for the comparative analysis (i.e. excluding early stand
counts and all the endpoints collected after harvest, see Sections 3.3.2 and 3.3.4.3).
Statistically significant differences were identified for six of those endpoints,22 which all fell
under equivalence category I or II.23
As explained in Section 3.3.4.3, the endpoint early stand count for oilseed rape MS11 treated with
the intended herbicide was considered not adequate for the comparative analysis because the GM
plants were planted at double seed density compared to the other plots. After spraying with the
intended herbicide, the plant density was reduced to levels comparable with the other plots. This is
confirmed by the fact that the endpoint final stand count fell under equivalence category I. Therefore,
the GMO Panel considered that this unusual management practice did not have an impact on the
comparative assessment.
3.3.7. Compositional analysis
As described in Section 3.3, the seeds produced from MS11 treated with intended herbicide
(scenario 4) have a heterogeneous genetic background influenced by the genotype of the pollen
produced from nearby plots. Hence, the compositional data for MS11 treated with intended herbicide
cannot be considered adequate for the comparative analysis. Without data for such material, the
compositional data set is considered incomplete and was not taken into account in the assessment.
The GMO Panel is therefore not in the position to complete the assessment of the compositional
analysis.
3.3.8. Conclusion on the comparative assessment
Under the specific theoretical cultivation scenarios considered, the GMO Panel concludes that none
of the differences identified in the agronomic and phenotypic characteristics tested between oilseed
rape MS11 and its conventional counterpart needs further assessment.
Because of the lack of an appropriate data set, the GMO Panel is not in the position to conclude on
the compositional analysis and can therefore not complete the comparative analysis.
3.4. Food/feed safety assessment
3.4.1. Effects of processing
Because the GMO Panel is not in the position to conclude on the compositional analysis and
therefore cannot complete the assessment of the comparative analysis, it is also not in the position to
assess the effect of processing of oilseed rape MS11.
3.4.2. Influence of temperature and pH on newly expressed proteins7
Effects of temperature and pH on the newly expressed proteins in this GM oilseed rape have been
previously evaluated by the GMO Panel (EFSA, 2006, 2007; EFSA GMO Panel, 2012, 2016a,b, 2017b,
c). Additional studies addressing heat stability of Barnase/barstar complex and the PAT/bar protein
were provided by the applicant (Appendix A). The outcome of these studies is consistent with similar
studies previous assessed by the GMO Panel.
21 Early stand count, final stand count, days to flowering (50% plants flower), days to flowering – 10% remains, days to
maturity, average plant height and seed yield.
22 Final stand count, days to flowering (50% plants flower), days to flowering – 10% remains, days to maturity, average plant
height.
23 Results for early stand count (plants/plot) were as follows: mean level for the comparator: 141.98; mean level for the GM
oilseed rape (treated with the intended herbicide): 263.74; equivalence limits: (87.00, 173.03).
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3.4.3. Toxicology
3.4.3.1. Testing of the newly expressed proteins
The three proteins newly expressed in oilseed rape MS11 (Barnase, Barstar and PAT/bar) have
been characterised in the context of this application (Section 3.2.3).
The PAT/bar protein was previously assessed by the GMO Panel in the context of other applications
(e.g. EFSA, 2005, 2006, 2007; EFSA GMO Panel, 2013, 2016a,b) and no safety concerns for humans
and animals were identified. Updated bioinformatics analyses reveal no similarities of the PAT/bar
protein with known toxins. Additional studies addressing in vitro degradation of the PAT/bar protein
were provided by the applicant (Appendix A). The outcome of these studies is consistent with previous
studies assessed by the GMO Panel (EFSA, 2006, 2007; EFSA GMO Panel, 2016a,b, 2017b,c). The GMO
Panel is not aware of any new information that would change previous conclusion on the safety of
PAT/bar proteins.
The Barnase and Barstar proteins have been already evaluated by the GMO Panel in the context of
previous applications (i.e. EFSA, 2005; EFSA GMO Panel, 2012, 2016b, 2017b,c) and not considered to
pose risk for food and feed, due to the specificity of the molecular transgenic constructs (time/tissue-
specific expression).
The GMO Panel noted that the barstar expression cassette in Ms11 differs from those previously
assessed; being under a constitutive promoter to counteract the possible unintended Barnase
expression in other plant tissues including those relevant for food and feed (Section 3.2.4).
A weight-of-evidence approach was followed in the context of the present application to exclude
potential safety concerns for human and animal health of Barnase and Barstar proteins and their
complex, taking into account the overall information presented in the dossier.
Updated bioinformatics analyses reveal no similarities of the Barnase and Barstar proteins known to
be toxins. Additional studies addressing in vitro degradation of the Barnase and Barstar proteins were
provided by the applicant (Appendix A). No indications of safety concern were identified by the GMO
Panel. The outcome of these studies is consistent with previous studies assessed by the EFSA GMO
Panel (EFSA GMO Panel, 2017b,c).
The available toxicological studies provided (acute oral gavage up to the dose of 2000 mg/kg body
weight to male and/or female mice administered microbially produced Barnase and Barstar proteins
and their combination; and 28 days by oral gavage7, alone or as a complex, respectively, up to the
highest doses of 9.5, 10 and 20 mg/kg body weight (bw) to male and female CD-1 mice did not reveal
adverse effects (Appendix A).
The GMO Panel does not identify concerns regarding the potential toxicity of the Barnase, Barstar
as expressed in this oilseed rape MS11.
Based on scientific knowledge, no synergistic or antagonistic interactions raising food/feed safety
concerns exist between the PAT/bar and the Barnase or Barstar proteins and their complex.
3.4.3.2. Testing of new constituents other than the newly expressed proteins
Since the GMO Panel is not in the position to conclude on the compositional analysis and therefore
cannot complete the assessment of the comparative analysis, it is also not in the position to complete
the assessment of new constituents other than the newly expressed proteins.
3.4.3.3. Information on altered levels of food/feed constituents
Since the GMO Panel is not in the position to conclude on the comparative analysis and therefore
cannot complete the assessment of the compositional analysis, it is also not in the position to complete
the assessment of altered levels of constituents.
3.4.3.4. Testing of the whole genetically modified food/feed
In accordance with Regulation (EU) No 503/2013, the applicant provided a 90-day oral repeated-
dose toxicity study on whole food/feed from oilseed rape MS11 in rats.
Since the GMO Panel is not in the position to conclude on comparative analysis, is not possible to
establish whether the 90-day study on Ms11 should be conducted according to a hypothesis-driven
design or not (EFSA, 2014); therefore, the GMO Panel did not assess the 90-day study provided in the
context of this application.
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3.4.4. Allergenicity
The strategies to assess the potential risk of allergenicity focus on the source of the recombinant
protein, on the potential of the newly expressed protein to induce sensitisation or to elicit allergic
reactions in already sensitised persons and on whether the transformation may have altered the
allergenic properties of the modified plant.
3.4.4.1. Assessment of allergenicity of the newly expressed proteins24
A weight-of-evidence approach was followed, taking into account all the information obtained on
the newly expressed protein, as no single piece of information or experimental method yield sufficient
evidence to predict allergenicity (Codex Alimentarius 2009; EFSA GMO Panel, 2011a; Regulation (EU)
No 503/2013).
The pat/bar gene originates from S. hygroscopicus, and the barnase and barstar genes originate
from B. amyloliquefaciens, none of which are considered allergenic sources.
Updated bioinformatic analyses of the amino acid sequences of the Barnase, Barstar and PAT/bar
proteins, using the criterion of 35% identity in a sliding window of 80 amino acids, revealed no
significant similarities to known allergens. In addition, the applicant performed analyses searching for
matches of eight contiguous identical amino acid sequences between these newly expressed protein
sequences and known allergens.25 The studies on resistance of the Barnase, Barstar and PAT/bar
proteins to degradation by pepsin have been described in Section 3.4.3.1.
The GMO Panel has previously evaluated the safety of the Barnase, Barstar and PAT/bar proteins
and no concerns on allergenicity were identified (EFSA 2006, 2007; EFSA GMO Panel 2012, 2016a,b,
2017b,c). As described above, it is also noted that the expression levels of Barnase and Barstar
proteins were below the LLOQ in oilseed rape MS11 tissues relevant for food and feed (i.e. seeds).
Nevertheless, expression levels of Barnase and Barstar above LLOQ cannot be completely excluded,
and a theoretical estimation of the maximum possible levels of Barnase and Barstar proteins was
considered (see Sections 3.2.4 and 3.4.5).
In addition, no information available on the structure or function of the newly expressed Barnase,
Barstar and/or PAT/bar proteins would suggest an adjuvant effect of these proteins in oilseed rape
MS11, resulting in or increasing an eventual immunoglobulin E (IgE) response to a bystander protein.
In the context of this application, the GMO Panel considers that there are no indications that the
newly expressed Barnase, Barstar and/or PAT/bar proteins in oilseed rape MS11 may be allergenic.
3.4.4.2. Assessment of allergenicity of the whole GM plant
Since the GMO Panel is not in the position to conclude on the compositional analysis and therefore
cannot complete the assessment of the comparative analysis, it is also not in the position to complete
the assessment of allergenicity of the whole GM plant.
3.4.5. Dietary exposure assessment of new constituents
In line with Regulation (EU) No 503/2013, dietary exposure to PAT/bar, Barnase and Barstar
proteins newly expressed in oilseed rape MS11 was estimated. Since oilseed rape MS11 is intended to
be used only for the production of hybrid seed and therefore is not expected to enter the food and
feed chain in the EU, except in the case of accidental presence in products coming from non-EU
countries, the dietary exposure scenarios shown below are considered to be overly conservative.
Dietary exposure was estimated based on protein expression levels reported for oilseed rape MS11
treated with the intended herbicide, the current available consumption data and feed practices, the
foods and feeds currently available in the market and the described processing conditions. All seed
samples analysed for Barnase and Barstar were below LLOQ. As a worst-case scenario, these LLOQs as
well as the information reported on the complexed and the uncomplexed fractions of these proteins
(see Section 3.2.4) were used when deriving the concentration values used for the exposure
estimations.
3.4.5.1. Human dietary exposure
Different food processed commodities can be produced from oilseed rape: protein-based products
(flours, concentrates, isolates), pollen supplements and oil.
24 Dossier: Part II – Section 1.5.1, 1.5.3 and additional information 24/1/2020.
25 Additional information 24/1/2020 (included in the ORF analysis).
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Exposure to PAT/bar, Barnase and Barstar proteins from the consumption of refined oil is expected
to be negligible since the processing of rape seeds to oil of food grade quality leads to the removal of
proteins. Likewise, oilseed rape MS11 is a male sterile rapeseed not producing any pollen; therefore,
pollen supplements would not contain any pollen from this crop. Regarding protein-based products
from oilseed rape, they might be used as protein/amino acids supplements and/or in a wide variety of
food applications (meat imitates, baked goods, ready-to-eat drinks, etc.). Taking into account the
intended use of oilseed rape MS11 (production of hybrid seed), the production of protein/amino acids
supplements from these seeds is highly unrealistic and, therefore, they were not considered in the
dietary exposure estimations. On the other hand, although being an overly conservative scenario, the
GMO Panel considers feasible the use of flours/concentrates containing oilseed rape MS11 to produce
meat imitates. Making use of the available consumption data on meat imitates in the EFSA
Comprehensive European Food Consumption Database (reported as ‘Textured soy protein’),26 the GMO
Panel requested to estimate chronic and acute dietary exposure to PAT/bar, Barnase and Barstar
proteins assuming that all meat imitates are made of oilseed rape MS11.
Initial concentrations for Barnase and Barstar in seeds were derived as explained in Section 3.2.4,
0.14 lg/g for Barnase and 0.145 lg/g for Barstar, both in fresh weight. For PAT/bar, the average
concentration in seeds was 0.49 lg/g fw (Table 1). No losses in the newly expressed proteins during
processing were considered; a factor (0.8) was applied on the average protein concentrations in the
seeds before they were used to estimate dietary exposure through the consumption of meat imitates.
The highest chronic dietary exposure in high consumers of meat imitates was estimated in the age
class ‘Other children’, with estimates of 0.91, 0.29 and 0.30 mg/kg bw day for PAT/bar, Barnase and
Barstar proteins, respectively. For the acute dietary exposure, high consumers of meat imitates would
be exposed to 1.2, 0.38 and 0.40 mg/kg bw day of PAT/bar, Barnase and Barstar proteins,
respectively, in ‘Other children’.
3.4.5.2. Animal dietary exposure27
Dietary exposure to PAT/bar, Barnase and Barstar proteins was provided by the applicant based on
the consumption of canola meal and rape forage across different animal species. Estimations took into
account protein levels in seeds and whole plant, as derived from replicated field trial sites in the 2014
Canada and US growing season.
Initial concentrations provided by the applicant for Barnase and Barstar proteins in seeds were
revised, considering both the complexed and the uncomplexed fractions of these proteins, as explained
in Section 3.2.4. The new data provided, together with those reported for the PAT/bar protein in
Table 1, were used by the GMO Panel to estimate dietary exposure across different animal species
(e.g. cattle, sheep, swine and poultry). The assessment was focused on the consumption of canola
meal, and estimates for animal body weight, daily feed intake and inclusion rates of canola meal, as
recommended by OECD for the EU animal population (OECD, 2013). To estimate the mean PAT/bar,
Barnase and Barstar protein levels in canola meal, a factor of 1.6-fold was applied based on the
protein content in this feed material relative to canola seed (OECD, 2011), assuming that no losses of
newly expressed protein occur during processing. Estimated dietary exposure in livestock is reported in
Table 3.
Table 3: Dietary exposure to PAT/bar, Barnase and Barstar proteins (lg/kg bw per day) in livestock,
based on the consumption of canola meal
Dietary exposure (lg/kg bw per day)
PAT/bar Barnase Barstar
Dairy cattle 3.01 0.97 1.01
Breeding swine 3.61 1.17 1.21
Finishing swine 4.70 1.52 1.58
Broiler 9.96 3.22 3.35
Layer 5.36 1.73 1.80
Turkey 11.2 3.62 3.77
26 Available online: https://www.efsa.europa.eu/en/applications/gmo/tools [Accessed: January 13, 2020]
27 Dossier: Part II – Section 1.6.2 and additional information: 26/11/2019; 4/3/2020.
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3.4.6. Nutritional assessment of endogenous constituents
Because the GMO Panel is not in the position to conclude on the compositional analysis and
therefore cannot complete the assessment of the comparative analysis, it is also not in the position to
complete the nutritional assessment of GM food/feed.
3.4.7. Post-market monitoring of GM food/feed
Because the GMO Panel is not in the position to conclude on the compositional analysis and
therefore cannot complete the assessment of the comparative analysis, and consequently on the food
and feed safety, it is also not in the position to comment on post-market monitoring of the GM food/
feed.
3.4.8. Conclusion on the food/feed safety assessment
The GMO Panel does not identify safety concerns regarding the potential toxicity and allergenicity
of the Barnase, Barstar and PAT/bar proteins as expressed in this oilseed rape MS11.
Due to the incompleteness of the comparative analysis, the GMO Panel is not in the position to
complete the toxicological, allergenicity and nutritional assessment of oilseed rape MS11.
3.5. Environmental risk assessment and monitoring plan28
3.5.1. Environmental risk assessment
Considering the scope of application EFSA-GMO-BE-2016-138, which excludes cultivation, the
environmental risk assessment (ERA) of oilseed rape MS11 mainly takes into account: (1) the exposure
of microorganisms to recombinant DNA in the gastrointestinal tract of animals fed GM material and of
microorganisms present in environments exposed to faecal material of these animals (manure and
faeces); and (2) the accidental release into the environment of viable oilseed rape MS11 seeds during
transportation and/or processing (EFSA GMO Panel, 2010b).
3.5.1.1. Persistence and invasiveness of the GM plant
Oilseed rape (Brassica napus) is an annual allotetraploid species (2n = 38, genome constitution
AACC), which has probably evolved through hybridisation and polyploidisation between the two diploid
species Brassica rapa (2n = 20, AA) and Brassica oleracea (2n = 18, CC). Oilseed rape seeds have the
ability to survive in soils for more than 10 years (Hails et al., 1997; Lutman et al., 2004, 2005, 2008;
Begg et al., 2006; Messean et al., 2007; D’Hertefeldt et al., 2008; Gruber et al., 2008; Beckie and
Warwick, 2010; Belter, 2016; Peltonen-Sainio et al., 2014) and demographic studies and surveys have
shown the ability of oilseed rape (B. napus) seed to establish self-perpetuating populations outside
agricultural areas, mainly in semi-natural and ruderal habitats in different countries (e.g. Devos et al.,
2012; COGEM, 2013; Bauer-Panskus et al., 2013; Hecht et al., 2014; Schulze et al., 2014; Katsuta
et al., 2015; Bailleul et al., 2016; Busi and Powles, 2016; Franzaring et al., 2016; Nishizawa et al.,
2016; Pandolfo et al., 2016; Pascher et al., 2017). Oilseed rape is generally regarded as an
opportunistic species, which can take advantage of disturbed sites (e.g. mowed areas, semi-natural
habitats) to germinate and capture resources rapidly. In undisturbed natural habitats, oilseed rape
lacks the ability to establish stable populations over successive years, possibly due to the absence of
competition-free germination sites (Crawley et al., 1993, 2001, Meffin et al., 2015) and exposure to
biological and abiotic stressors likely limiting fitness (COGEM, 2013; Busi and Powles, 2016). Once
established in competition-free germination sites, feral populations decline over a period of years
(Crawley and Brown, 1995, 2004; Knispel et al., 2008; Squire et al., 2011; Banks, 2014; Busi and
Powles, 2016). However, if habitats are disturbed on a regular basis, then feral populations can persist
for longer periods (Pessel et al., 2001; Claessen et al., 2005a,b; Garnier et al., 2006; Elling et al.,
2009; Pascher et al., 2010; Banks, 2014) and can have the characteristics of a weed or ruderal (Banks,
2014). The persistence or recurrence of a population in one location is variously attributed to
replenishment with fresh seed spills, to recruitment from seed emerging from the soil seed bank or
shed by resident feral adult plants, or to redistribution of feral seed from one location to another
(Pivard et al., 2008a,b; Banks, 2014; Bailleul et al., 2016). Banks (2014) showed that the substantial
28 Dossier: Part II – Sections 5 and 6.
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increase in small and large (100 to 1,000 plants) feral populations occurred throughout the studied
area during study years in Scotland.
It is expected that the intended traits of oilseed rape MS11 will provide a selective disadvantage to
oilseed rape plants, even when they are exposed to glufosinate-ammonium-containing herbicides.
Oilseed rape MS11 expresses the barnase gene, which results in lack of viable pollen and thus male
sterility. Consequently, oilseed rape MS11 plants cannot transmit genes through pollen, and can only
set seed if pollinated by another oilseed rape plant, which substantially reduces the fitness of oilseed
rape MS11 plants.
In conclusion, the GMO Panel considers that oilseed rape MS11 will have reduced ability to survive
and establish feral populations under European environmental conditions in case of accidental release
into the environment of viable oilseed rape MS11 seeds compared to conventional oilseed rape
varieties.
3.5.1.2. Potential for gene transfer
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic
material, either through HGT of DNA or through vertical gene flow via cross-pollination from feral
plants originating from spilled seeds.
3.5.1.2.1. Plant-to-microorganism gene transfer
Genomic DNA can be a component of food and feed products derived from oilseed rape. It is well
documented that such DNA becomes substantially degraded during processing and digestion in the
human or animal gastrointestinal tract. However, bacteria in the digestive tract of humans and animals,
and in other environments, may be exposed to fragments of DNA, including the recombinant fraction
of such DNA.
Current scientific knowledge of recombination processes in bacteria suggests that horizontal
transfer of non-mobile, chromosomally located DNA fragments between unrelated organisms (such as
from plants to bacteria) is not likely to occur at detectable frequencies under natural conditions (for
further details, see EFSA, 2009).
The only mechanism known to facilitate horizontal transfer of non-mobile, chromosomal DNA
fragments to bacterial genomes is homologous recombination. This requires the presence of at least
two stretches of DNA sequences that are similar in the recombining DNA molecules. In the case of
sequence identity with the transgene itself, recombination would result in gene replacement. In the
case of identity with two or more regions flanking recombinant DNA, recombination could result in the
insertion of additional DNA sequences in bacteria and thus confer the potential for new properties.
In addition to homology-based recombination processes, at a lower transformation rate, the non-
homologous end joining and microhomology-mediated end joining are theoretically possible (EFSA,
2009; H€ulter and Wackernagel, 2008). Independently of the transfer mechanism, the GMO Panel did
not identify a selective advantage that a theoretical HGT would provide to bacterial recipients in the
environment.
The updated bioinformatic analysis of event MS11 revealed three pairs of DNA sequences with
sufficient length and sequence identity to bacterial DNA (EFSA, 2017b). These are the two 30 g7
terminators from the octopine Ti plasmid of A. tumefaciens; the 30 nos terminator and the P-nos
promotor of the nopaline Ti plasmid of A. tumefaciens; and barstar and barnase of the
B. amyloliquefaciens. The barstar and barnase genes show sequence identity with DNA from
B. amyloliquefaciens. Homologous recombination would only replace natural variants of such genes,
and thus not conferring any new trait to bacterial recipients. Given the nature of the transferred DNA,
a facilitated double homologous recombination would not provide a selective advantage to potential
bacterial recipients. The GMO Panel identifies no safety concern linked to an unlikely but theoretically
possible horizontal gene transfer.
In summary, there is no indication for an increased likelihood of horizontal transfer of DNA from
oilseed rape MS11 to bacteria. Given the nature of the recombinant DNA, the GMO Panel identified no
safety concern linked to an unlikely but theoretically possible HGT.
3.5.1.2.2. Plant-to-plant gene transfer
For plant-to-plant gene transfer to occur, imported GM oilseed rape seeds need to germinate and
develop into plants in areas containing sympatric wild relatives and/or cultivated oilseed rape with
synchronous flowering and environmental conditions favouring cross-pollination.
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Oilseed rape is an open pollinating crop plant capable of cross-pollinating with other Brassica crops
(Eastham and Sweet, 2002). It can also spontaneously hybridise with sexually compatible feral and
wild relatives. Several hybrids between oilseed rape and wild relatives have been reported in the
scientific literature. Evidence suggests that transgenes could readily introgress into B. rapa, B. juncea
and B. oleracea, and is expected to be rare with B. nigra, Hirschfeldia incana, Raphanus raphanistrum
and Sinapis arvensis (reviewed by FitzJohn et al., 2007; Devos et al., 2009; Liu et al., 2013; Ellstrand
et al., 1999, 2013; Tang et al., 2018). Under field conditions, transgene introgression has only been
confirmed for B. rapa (Hansen et al., 2001, 2003; Warwick et al., 2003; Jørgensen et al., 2004; Norris
et al., 2004; Jørgensen, 2007; Warwick et al., 2008). For transgene introgression to occur, feral GM
oilseed rape must require some overlap in flowering in time and space with compatible relatives.
Subsequently, transgenes must be transmitted through successive backcross generations or selfing, so
that they become stabilised into the genome of the recipient (de Jong and Rong, 2013; Garnier et al.,
2014). Because of these barriers (Luijten et al., 2015), reported incidences of hybrids and backcrosses
with B. rapa were found to be low in fields (Jørgensen et al., 2004; Norris et al., 2004; Warwick et al.,
2008; Elling et al., 2009), or at ports, along roadsides and riverbanks (Saji et al., 2005; Yoshimura
et al., 2006; Aono et al., 2006, 2011; Elling et al., 2009; Katsuta et al., 2015; Luijten et al., 2015).
The likelihood of gene flow from feral oilseed rape MS11 plants to sexually compatible feral plants
and wild relatives will be substantially reduced compared to other feral oilseed rape plants, because
oilseed rape MS11 plants are male sterility. Consequently, gene flow will be limited to seed dispersal,
as feral oilseed rape MS11 plants can set seed if pollinated by other feral oilseed rape plants (see
Section 3.5.1.1).
In conclusion, the GMO Panel considers that the likelihood of environmental effects because of the
spread of genes from oilseed MS11 rape in Europe will be lower than that of conventional oilseed rape
varieties.
3.5.1.3. Interactions of the GM plant with target organisms
Taking the scope of application EFSA-GMO-BE-2016-138 (no cultivation) and thus the absence of
target organisms into account, potential interactions of feral oilseed rape MS11 plants arising from
seed import spills with target organisms are not considered a relevant issue.
3.5.1.4. Interactions of the GM plant with non-target organisms
Given that environmental exposure of non-target organisms to spilled GM seeds or feral GM oilseed
rape plants arising from spilled oilseed rape MS11 seeds is limited, and because ingested proteins are
degraded before entering the environment through faecal material of animals fed GM oilseed rape,
potential interactions of the oilseed rape MS11 with non-target organisms are not considered by the
GMO Panel to raise any environmental safety concern.
3.5.1.5. Interactions with the abiotic environment and biogeochemical cycles
Given that environmental exposure to spilled seeds or feral oilseed rape MS11 plants arising from
seed import spills is limited, and because most proteins are degraded before entering the environment
through faecal material of animals fed GM oilseed rape, potential interactions with the abiotic
environment and biogeochemical cycles are not considered by the GMO Panel to raise any
environmental safety concern.
3.5.2. Post-market environmental monitoring
The objectives of a PMEM plan, according to Annex VII of Directive 2001/18/EC, are to: (1) confirm
that any assumption regarding the occurrence and impact of potential adverse effects of the GMO, or
its use, in the ERA are correct; and (2) identify the occurrence of adverse effects of the GMO, or its
use, on human health or the environment that were not anticipated in the ERA.
Monitoring is related to risk management, and thus, a final adoption of the PMEM plan falls outside
the mandate of EFSA. However, the GMO Panel gives its opinion on the scientific rationale of the PMEM
plan provided by the applicant (EFSA GMO Panel, 2011b).
As the ERA does not identify potential adverse environmental effects from the oilseed rape MS11,
no case-specific monitoring is required.
The PMEM plan proposed by the applicant for oilseed rape MS11 includes: (1) the description of an
approach involving operators (federations involved in import and processing), reporting to the
applicant, via a centralised system, any observed adverse effect(s) of GMOs on human health and the
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environment; (2) a coordinating system established by EuropaBio for the collection of information
recorded by the various operators; and (3) the review of relevant scientific publications retrieved from
literature searches (Lecoq et al., 2007; Windels et al., 2008). The applicant proposes to submit a
PMEM report on an annual basis and a final report at the end of the authorisation period.
The GMO Panel considers that the PMEM plan proposed by the applicant is in line with the scope of
the application. The GMO Panel agrees with the reporting intervals proposed by the applicant in its
PMEM plan.
In the context of PMEM, the applicant could further improve future literature searches according to
the GMO Panel recommendations given in Section 3.1.
3.5.3. Conclusions on the environmental risk assessment and monitoring plan
The GMO Panel concludes that oilseed rape MS11 will have reduced ability to persist under
European environmental conditions compared to conventional oilseed rape varieties. Considering the
scope of the application EFSA-GMO-BE-2016-138, interactions of feral oilseed rape MS11 plants with
the biotic and abiotic environment are not considered to be relevant issues. The analysis of HGT from
oilseed rape MS11 to bacteria does not indicate a safety concern. Therefore, considering the
introduced traits, the outcome of the agronomic and phenotypic analysis and the routes and levels of
exposure, the GMO Panel concludes that oilseed rape MS11 would not raise safety concerns in the
event of accidental release of viable GM oilseed rape seeds into the environment.
The GMO Panel considers that the PMEM plan proposed by the applicant is in line with the scope of
the application and agrees with the reporting intervals of the PMEM plan.
4. Conclusions
The GMO Panel was asked to carry out a scientific assessment of oilseed rape MS11, subject of the
application EFSA-GMO-BE-2016-138. In line with the scope of this application which is for import,
processing and food and feed uses in accordance with Regulation (EC) No 1829/2003, the GMO
Panel concludes that:
• The molecular characterisation data establish that oilseed rape MS11 contains a single insert
consisting of one copy of the barnase, barstar and pat/bar expression cassettes. Bioinformatic
analyses of the sequences encoding the newly expressed proteins and other ORFs present
within the insert or spanning the junctions between the insert and genomic DNA do not
indicate significant similarities to toxins and allergens. The stability of the inserted DNA and
introduced herbicide trait was confirmed over several generations. The levels of the Barnase,
Barstar and PAT/bar proteins were obtained and reported adequately. The information
provided on the protein characterisation indicate that the plant- and E.coli-produced Barnase,
Barstar and PAT/bar proteins are equivalent and the E.coli-produced proteins can be used in
the safety studies.
• The characteristics of the introduced traits of oilseed rape MS11 challenge the comparative
analysis to the extent that it is not possible to produce the materials and collect the data for
the comparative analysis without deviating from the requirements laid down in Regulation (EU)
No 503/2013. None of the differences between oilseed rape MS11 and its conventional
counterpart identified in the agronomic and phenotypic characteristics tested under the specific
theoretical cultivation scenarios needs further assessment. Because of the heterogeneous
genetic background of the seeds produced from oilseed rape MS11 treated with the intended
herbicide, the compositional data cannot be considered adequate for the comparative analysis.
Hence, no conclusions can be drawn for the compositional analysis.
• No safety concerns are identified regarding the toxicity and allergenicity of the Barnase,
Barstar and PAT/bar proteins, as expressed in oilseed rape MS11. Owing to the incompleteness
of the compositional analysis, the toxicological, allergenicity and nutritional assessment of
oilseed rape MS11 cannot be completed.
• Oilseed rape MS11 would not raise safety concerns in the event of accidental release of viable
GM oilseed rape seeds into the environment.
• The post-market environmental monitoring (PMEM) plan proposed by the applicant is in line
with the scope of the application and agrees with its reporting intervals.
• Based on the relevant publications identified through the literature searches, no safety issues
pertaining to the uses of oilseed rape MS11 were identified. In the context of PMEM, the
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applicant could further improve future literature searches according to the GMO
Panel recommendations. In addition, the information in additional unpublished studies
(Appendix A) does not raise any concern for human and animal health and the environment,
regarding oilseed rape MS11.
• In conclusion, in the absence of an appropriate comparative assessment and considering the
scope of application EFSA-GMO-BE-2016-138 as defined by the applicant (food and feed uses,
import and processing), the GMO Panel is not in a position to complete its food/feed
assessment of oilseed rape MS11. However, oilseed rape MS11 is unlikely to have any adverse
effect on the environment in the context of the scope of the application.
The GMO Panel notes that oilseed rape MS11 is designed to be used only for the production of
hybrid seed in the frame of a dedicated breeding system and thus is not expected to be
commercialised as a stand-alone product for food/feed uses. Therefore, seeds harvested from oilseed
rape MS11 are not expected to enter the food/feed chain except in the case of accidental presence in
products coming from non-EU countries. In this context, the GMO Panel therefore notes the following:
• The conclusions on the molecular characterisation data remain unchanged;
• With regard to food and feed safety, no concerns have been identified regarding the toxicity
and allergenicity of the Barnase, Barstar and PAT/bar proteins, as expressed in oilseed rape
MS11. Human and animal exposure to food and feed containing, consisting of or derived from
oilseed rape MS11 (single event) is only expected to occur through the accidental entry of
oilseed rape MS11 seeds into the food and feed chain, leading to a scale of exposure
substantially reduced compared to a stand-alone product. In addition, no variations in the level
of compound(s) of this GM plant are expected based on the intended trait. Taking the above
into account, it is considered that in case of accidental exposure, oilseed rape MS11 would not
pose risk to humans and animals;
• The conclusions on ERA and PMEM remain unchanged, furthermore, the scale of
environmental exposure through the accidental release of viable oilseed rape MS11 seeds
during transportation and/or processing will be substantially reduced compared to a stand-
alone product.
5. Documentation as provided to EFSA
• Letter from the Competent Authority of Belgium received on 16 December 2016 concerning a
request for authorization of the placing on the market of Brassica napus MS11 submitted in
accordance with Regulation (EC) No 1829/2003 by Bayer CropScience.
• Application EFSA-GMO-BE-2016-138 validated by EFSA, 08 March 2017.
• Request for supplementary information to the applicant, 22 March 2017.
• Receipt of spontaneous information from the applicant, 05 May 2017.
• Request for supplementary information to the applicant, 12 May 2017.
• Receipt of supplementary information from the applicant, 31 May 2017.
• Request for supplementary information to the applicant, 21 June 2017.
• Request for supplementary information to the applicant, 22 June 2017.
• Request for supplementary information to the applicant, 07 July 2017.
• Receipt of supplementary information from the applicant, 10 July 2017.
• Receipt of supplementary information from the applicant, 11 August 2017.
• Receipt of supplementary information from the applicant, 10 July 2017.
• Receipt of spontaneous information from the applicant, 26 September 2017.
• Request for supplementary information to the applicant, 26 September 2017.
• Receipt of supplementary information from the applicant, 04 October 2017.
• Request for supplementary information to the applicant, 13 November 2017.
• Receipt of spontaneous information from the applicant, 17 November 2017.
• Request for supplementary information to the applicant, 21 December 2017.
• Receipt of supplementary information from the applicant, 19 January 2018.
• Receipt of supplementary information from the applicant, 13 March 2018.
• Request for supplementary information to the applicant, 21 March 2018.
• Receipt of supplementary information from the applicant, 27 April 2018.
• Request for supplementary information to the applicant, 04 May 2018.
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Assessment of oilseed rape MS11
www.efsa.europa.eu/efsajournal 25 EFSA Journal 2020;18(5):6112
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• Receipt of supplementary information from the applicant, 24 August 2018.
• Request for supplementary information to the applicant, 18 September 2018.
• Receipt of supplementary information from the applicant, 19 November 2018.
• Request for supplementary information to the applicant, 18 December 2018.
• Receipt of supplementary information from the applicant, 18 January 2019.
• Request for supplementary information to the applicant, 07 March 2019.
• Receipt of supplementary information from the applicant, 01 April 2019.
• Request for supplementary information to the applicant, 16 April 2019.
• Receipt of supplementary information from the applicant, 14 June 2019.
• Receipt of spontaneous information from the applicant, 25 June 2019.
• Request for supplementary information to the applicant, 02 August 2019.
• Receipt of supplementary information from the applicant, 10 September 2019.
• Request for supplementary information to the applicant, 11 October 2019.
• Receipt of supplementary information from the applicant, 21 November 2019.
• Request for supplementary information to the applicant, 26 November 2019.
• Receipt of supplementary information from the applicant, 24 January 2020.
• Receipt of spontaneous information from the applicant, 04 March 2020.
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Abbreviations
bp base pair
ELISA enzyme-linked immunosorbent assay
ERA environmental risk assessment
GM genetically modified
GMO genetically modified organism
HGT horizontal gene transfer
HR homologous recombination
IgE immunoglobulin E
Nos nopaline synthase
OECD Organisation for Economic Co-operation and Development
ORF open reading frame
PAT phosphinothricin acetyl-transferase
PMEM post-market environmental monitoring
RF restores fertility
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Appendix A – List of additional studies performed by or on behalf of the
applicant with regard to the evaluation of the safety of oilseed rape MS11
for humans, animal or the environment
Study
identification
Title
M-365250-01-1 Barstar protein - Acute toxicity by oral gavage in mice
M-429793-01-1 Barstar protein in vitro digestibility study in human simulated gastric fluid at pH 1.2
M-429800-02-1 Barstar protein - In vitro digestibility study in human simulated intestinal fluid - Report
amendment no 1 of final report (Amended: 2016-05-19)
M-440532-01-1 The heat stability of microbially produced Barnase assessed by SDS-PAGE and western blot
analyses
M-461494-01-1 Recombinant PAT/bar protein: Acute toxicity by oral gavage in female mice
M-468940-01-1 Recombinant Barnase/Barstar complex protein: Acute toxicity by oral gavage in mice
M-474414-01-1 Recombinant Barnase protein - Acute toxicity by oral gavage in mice
M-475319-01-1 PAT/bar protein - Acute toxicity by oral gavage in mice
M-475710-01-1 The effect of temperature on microbially produced Barnase assessed by ELISA
M-476903-01-1 Recombinant Barnase/Barstar complex protein: In vitro digestibility study in human
simulated gastric fluid at pH 1.2
M-476904-01-1 Recombinant barnase/barstar complex protein: In vitro digestibility study in human
simulated intestinal fluid
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